Hierarchy neural networks as applied to pharmaceutical problems

Advanced Drug Delivery Reviews

Volumn 55, Issue 9, 2003, Pages 1119-1147

  Ichikawa, Hiroshi ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Artificial neural network; Backpropagation, Reconstruction; Basic theory of operation; Correlation between input and output; Descriptor mapping; Forgetting; Hierarchy; Partial derivative

Indexed keywords

BACKPROPAGATION; MEDICAL PROBLEMS; NEURAL NETWORKS; REGRESSION ANALYSIS; VECTORS;

MULTIREGRESSION ANALYSIS;

DRUG THERAPY;

NORBORNANE DERIVATIVE; NORBORNENE DERIVATIVE; QUINONE DERIVATIVE;

ARTIFICIAL NEURAL NETWORK; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; MATHEMATICAL ANALYSIS; NERVE CELL; NONLINEAR SYSTEM; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; SIMULATION; STRUCTURE ACTIVITY RELATION; THEORY;

EID: 0042884387     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(03)00115-7     Document Type: Article

References (44)

1. Kandel E.R., Schwarz J.H. Principle of Neural Science. 1982;Elsevier, North-Holland, New York.
2. Rumelhart D.E., McClelland J.L. Parallel Distributed Processing, Explorations in the Microstructure of Cognition. Vols. 1 and 2:1986;MIT Press, Cambridge, MA.
3. Hopfield J.J. Neural network and physical systems with emergent collective computational abilities. Proc. Natl. Acad. Sci. USA. 79:1982;2445-2558.
4. Hopfield J.J. Neurons with graded response have collective computational properties like those of two-state neurons. Proc. Natl. Acad. Sci. USA. 81:1984;3088-3092.
5. D.H. Acley, G.E. Hinton, T.J. Sejnowski, A Learning Algorithm for Bolzmann Machine, Cognitive Sci. 9, 1985.
6. Zupan J., Gasteiger J. Neural Networks in Chemistry and Drug Design. 2nd Edition: 1999;Wiley-VCH, Weinheim.
7. Kohonen T. Analysis of a simple self-organizing process. Biol. Cybern. 43:1982;59-62.
8. Kohonen T. Self-Organization and Associative Memory. 3rd Ed: 1989;Springer, Berlin.
9. Anzali S., Garnickel G., Krug M., Sadowski J., Wagener M., Gasteiger J. Evaluation of molecular surface properties using a Kohonen neural network. Devillers J. Neural Networks in QSAR and Drug Design. 1996;Academic Press, London.
10. Doucet J.P., Panaye A. 3D Structural information: from property prediction to substructure recognition with neural networks. SAR QSAR Environ. Res. 8:1998;249-272.
11. Aoyama T., Suzuki Y., Ichikawa H. Neural networks applied to pharmaceutical problems. I. Method and application to decision making. Chem. Pharm. Bull. 37:1989;2558-2560.
12. Aoyama T., Suzuki Y., Ichikawa H. Neural networks applied to structure-activity relationships. J. Med. Chem. 33:1990;905-908.
13. Devillers J. Neural Networks in Qsar and Drug Design. 1996;Academic Press, London.
14. Winkler D.A., Madellena D.J. QSAR and neural networks in life sciences. Ser. Math. Biol. Med. 5:1994;126-163.
15. Manallack D., Livingstone D.J. Neural networks and expert systems in molecular design. Methods Princ. Med. Chem. 3:1995;293-318.
16. Anzali S., Gasteiger J., Holzgrabe U., Polanski J., Sadowski J., Techentrup A., Markus M. The use of self-organizing neural networks in drug design. 3D QSAR Drug Design. 2:1998;273-299.
17. Maddalena D.J. Applications of soft computing in drug design. Exp. Opin. Ther. Pat. 8:1998;249-258.
18. Savid T., Livingstone D.J. Neural networks in drug discovery: have they lived up to their promise? Eur. J. Med. Chem. 34:1999;195-208.
19. Brier M.E., Aronoff G.R. Application of artificial neural networks to clinical pharmacology. Int. J. Clin. Pharmacol. Ther. 34:1996;510-514.
20. Rui J., Ling S. Neural networks model and its application in clinical pharmacology. Zhongguo Linchuang Yaolixue Zazhi. 13:1997;170-176. Chinese.
21. Tafeit E., Reibnegger G. Artificial neural networks in laboratory medicine and medical outcome prediction. Clin. Chem. Lab. Med. 37:1999;845-853.
22. Agatonovic-Kustrin S., Beresford R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J. Pharm. Biomed. Anal. 22:2000;717-727.
23. Nagl S. Neural network models of protein domain evolution. Hyle. 6:2000;143-159.
24. Ochoa C., Chana A. Applications of neural networks in the medicinal chemistry field. Curr. Med. Chem.: Central Nervous System Agents. 1:2001;247-256.
25. Cai Y., Gong J., Cheng Z., Chen N. Artificial neural network method for quality estimation of traditional Chinese medicine. Zhongcaoyao. 25:1994;187-189. Chinese.
26. Qiao Y.J., Wang X., Bi K.S., Luo X. Application of artificial neural networks to the feature extraction in chemical pattern recognition of the traditional Chinese medicine. Venenum bufonis, Yaoxue Xuebao. 30:1995;698-701. Chinese.
27. Geng L., Luo A., Fu R., Li J. Identification of Chinese herbal medicine using artificial neural network in pyrolysis-gas chromatography. Fenxi Huaxue. 28:2000;549-553. Chinese.
28. Bourquin J., Schmidli H., van Hoogevest P., Leuenberger H. Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. Pharm. Dev. Technol. 2:1997;95-109.
29. Takayama K., Fujikawa M., Nagai T. Artificial neural network as a novel method to optimize pharmaceutical formulations. Pharm. Res. 16:1999;1-6.
30. Rowe R.C., Roberts R.J. Artificial intelligence in pharmaceutical product formulation: neural computing and emerging technologies. Pharm. Sci. Technol. Today. 1:1998;200-205.
31. Takagi T. Pharmacometrics. New region in pharmaceutical science. Farumashia. 37:2001;695-699.
32. McCulloch W.S., Pitts W. A logical calculus of the ideas imminent in nervous activity. Bull. Math. Biophys. 5:1943;115-133.
33. Hebb D.O. The Organization of Behavior. 1949;Wiley, New York.
34. Aoyama T., Ichikawa H. Reconstruction of weight matrices in neural networks. A method of correlating output with inputs. Chem. Pharm. Bull. 39:1991;1222-1228.
35. Aoyama T., Suzuki Y., Ichikawa H. Neural networks as applied to quantitative structure-activity relationship analysis. J. Med. Chem. 33:1990;2583-2590.
36. Minsky M., Papert S. Perceptrons: An Introduction To Computational Geometry. 1969;MIT Press, Cambridge, MA.
37. Aoyama T., Ichikawa H. Basic operating characteristics of neural networks when applied to structure-activity studies. Chem. Pharm. Bull. 39:1991;358-366.
38. Moriguchi I., Komatsu K. Adaptive least-squares classification applied to structure-activity correlation al antitumor mitomycin derivatives. Chem. Pharm. Bull. 25:1977;2800-2802.
39. Aoyama T., Ichikawa H. Obtaining the correlation indices between drug activity and structural parameters using a neural network. Chem. Pharm. Bull. 39:1991;372-378.
40. Aoyama T., Ichikawa H. Neural networks as nonlinear structure-activity relationship analyzers. Useful functions of the partial derivative method in multilayer neural networks. J. Chem. Inform., Conmut. Sci. 32:1992;492-500.
41. Kowalski B.R. Chemometrics: Theory and Applications. ACS Symposium Series. 53:1977;43 American Chemical Society, Washington, DC.
42. Ichikawa H., Aoyama A. How to see characteristics of structural parameters in QSAR analysis: descriptor mapping using neural networks. SAR QSAR Envirn. Res. 1:1993;115-130.
43. Andrea T.A., Kalayeh H. Applications of neural networks in quantitative structure-activity relationships of dihydrofolate reductase inhibitors. J. Med. Chem. 34:1991;2824-2836.
44. Yoshimoto M., Miyazawa H., Nakao H., Shinkai K., Arakawa M. Quantitative structure-activity relationships in 2,5-bis(1-aziridinyl)-p-benzoquine derivatives against leukemia L-1210. J. Med. Chem. 22:1979;491-496.